“The Washington Post”: The resumption of Johnson & Johnson vaccine trials against Corona very soon

0
52


Reuters

/FW1F/Bill Berkrot

Johnson & Johnson Corporation is headquartered in California

The American “Washington Post” newspaper said that the Johnson & Johnson vaccine trials against Corona will resume “very soon.”

According to the newspaper, an independent committee investigated the case of a participant in the experiments who had a stroke, and concluded that his disease was not related to the vaccine.

On October 12, the company said that it had temporarily suspended clinical trials of the “Covid-19” vaccine after one of the volunteers in the study contracted an unexplained disease, which led to the disruption of one of the largest efforts made to contain the global epidemic.

Johnson & Johnson’s move came after a similar measure taken by AstraZeneca last September, due to the illness of one of the volunteers in the British study.

Source: Agencies





LEAVE A REPLY

Please enter your comment!
Please enter your name here